Fulcrum Therapeutics (FULC) Other Non-Current Assets (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Other Non-Current Assets data on file, last reported at $546000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 54.54% year-over-year to $546000.0 in Q1 2026; TTM through Mar 2026 was $546000.0, a 54.54% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, up 11910.0% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $546000.0, down from $1.2 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for FULC reached as high as $2.1 million in Q4 2022 and fell as low as $10000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $1.0 million across 5 years, with a median of $1.1 million in 2022.
• Across the five-year window, Other Non-Current Assets sank 99.08% in 2024 and jumped 11910.0% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.1 million in 2022, then tumbled by 48.12% to $1.1 million in 2023, then sank by 99.08% to $10000.0 in 2024, then soared by 11910.0% to $1.2 million in 2025, then plunged by 54.54% to $546000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $546000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.